[go: up one dir, main page]

NO20030296D0 - Heparin-derived polysaccharide mixtures, their preparation and pharmaceutical compositions containing the compositions - Google Patents

Heparin-derived polysaccharide mixtures, their preparation and pharmaceutical compositions containing the compositions

Info

Publication number
NO20030296D0
NO20030296D0 NO20030296A NO20030296A NO20030296D0 NO 20030296 D0 NO20030296 D0 NO 20030296D0 NO 20030296 A NO20030296 A NO 20030296A NO 20030296 A NO20030296 A NO 20030296A NO 20030296 D0 NO20030296 D0 NO 20030296D0
Authority
NO
Norway
Prior art keywords
heparin
preparation
derived polysaccharide
compositions
pharmaceutical compositions
Prior art date
Application number
NO20030296A
Other languages
Norwegian (no)
Other versions
NO20030296L (en
Inventor
Jacques Diaz
Christelle Pecquet
Elisabeth Perrin
Christian Viskov
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8852768&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20030296(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of NO20030296L publication Critical patent/NO20030296L/en
Publication of NO20030296D0 publication Critical patent/NO20030296D0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078—Degradation products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Materials Engineering (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
NO20030296A 2000-07-21 2003-01-20 Heparin-derived polysaccharide mixtures, their preparation and pharmaceutical compositions containing the compositions NO20030296D0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0009572A FR2811992B1 (en) 2000-07-21 2000-07-21 MIXTURES OF HEPARIN-DERIVED POLYSACCHARIDES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
PCT/FR2001/002332 WO2002008295A1 (en) 2000-07-21 2001-07-18 Heparin-derived polysaccharide mixtures, preparation method and pharmaceutical compositions containing same

Publications (2)

Publication Number Publication Date
NO20030296L NO20030296L (en) 2003-01-20
NO20030296D0 true NO20030296D0 (en) 2003-01-20

Family

ID=8852768

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030296A NO20030296D0 (en) 2000-07-21 2003-01-20 Heparin-derived polysaccharide mixtures, their preparation and pharmaceutical compositions containing the compositions

Country Status (35)

Country Link
EP (1) EP1307491B2 (en)
JP (1) JP5279160B2 (en)
KR (1) KR100853585B1 (en)
CN (1) CN1230449C (en)
AP (1) AP1703A (en)
AR (1) AR029865A1 (en)
AT (1) ATE470679T1 (en)
AU (2) AU7760201A (en)
BR (1) BR0112612B1 (en)
CA (1) CA2416673C (en)
CL (1) CL2004001154A1 (en)
CY (1) CY1110774T1 (en)
DE (1) DE60142340D1 (en)
DK (1) DK1307491T3 (en)
DZ (1) DZ3411A1 (en)
EA (1) EA005995B1 (en)
EC (1) ECSP034442A (en)
ES (1) ES2347134T5 (en)
FR (1) FR2811992B1 (en)
HR (1) HRP20030019A2 (en)
HU (1) HUP0300755A3 (en)
IL (2) IL153922A0 (en)
MA (1) MA26928A1 (en)
MX (1) MXPA03000579A (en)
NO (1) NO20030296D0 (en)
NZ (1) NZ524028A (en)
OA (1) OA12340A (en)
PL (1) PL202471B1 (en)
PT (1) PT1307491E (en)
SI (1) SI1307491T1 (en)
TW (1) TWI307278B (en)
UA (1) UA74836C2 (en)
WO (1) WO2002008295A1 (en)
YU (1) YU2903A (en)
ZA (1) ZA200300898B (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6969705B2 (en) 2000-07-21 2005-11-29 Aventis Pharma S.A. Compositions of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
ATE356150T1 (en) * 2002-06-20 2007-03-15 Chemi Spa METHOD FOR PRODUCING HEPARINE ESTERS
US20040171819A1 (en) 2002-10-10 2004-09-02 Aventis Pharma S.A. Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
FR2845686B1 (en) 2002-10-10 2013-08-30 Aventis Pharma Sa MIXTURES OF HEPARIN-DERIVED POLYSACCHARIDES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AR041555A1 (en) 2002-10-10 2005-05-18 Aventis Pharma Sa MIXTURES OF POLYACARIDS DERIVED FROM HEPARINE, ITS PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
US7956046B2 (en) * 2003-07-24 2011-06-07 Aventis Pharma S.A. Oligosaccharide mixtures derived from heparin, preparation thereof and pharmaceutical compositions containing them
FR2857971B1 (en) * 2003-07-24 2005-08-26 Aventis Pharma Sa MIXTURES OF HEPARIN DERIVED OLIGOSACCHARIDES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DE102004059134B4 (en) 2004-12-08 2011-12-15 Siemens Ag Expansion device for an X-ray machine and X-ray source
FR2889078B1 (en) * 2005-07-27 2007-11-02 Aventis Pharma Sa NOVEL CHROMATOGRAPHY METHOD OF AFFINITY OF ANTITHROMBIN III
WO2007140231A2 (en) * 2006-05-25 2007-12-06 Momenta Pharmaceutical, Inc. Low molecular weight heparin composition and uses thereof
CN101824099B (en) * 2010-02-12 2011-11-30 淮安麦德森化学有限公司 Method for purifying crude product heparin sodium
CN101824446B (en) * 2010-02-24 2012-12-12 淮安麦德森化学有限公司 Method for producing chondroitin sulfate by reverse precipitation
EP2399591A1 (en) 2010-06-25 2011-12-28 Aventis Pharma S.A. Semuloparin for the extended prevention of a mortality and/or morbidity event in a patient having undergone hip fracture surgery
EP2399592A1 (en) 2010-06-25 2011-12-28 Aventis Pharma S.A. Semuloparin for use as an antithrombotic treatment in hip replacement surgery with improved safety in terms of clinically relevant bleedings and major bleedings
EP2399590A1 (en) 2010-06-25 2011-12-28 Aventis Pharma S.A. Semuloparin for the prevention of a mortality and/or morbidity event in a patient undergoing major orthopaedic surgery
EP2399593A1 (en) 2010-06-28 2011-12-28 Aventis Pharma S.A. Semuloparin for use as an antithrombotic treatment in orthopaedic surgery with improved benefit-risk profile
CN102399379B (en) * 2010-09-09 2016-08-31 上海喜恩医药科技发展有限公司 Polysaccharide mixture of a kind of heparin derivative and preparation method thereof and pharmaceutical composition
KR101847846B1 (en) * 2010-09-14 2018-04-11 고쿠리츠 다이가쿠 호징 미야자키 다이가쿠 High purity heparin and production method therefor
WO2012055843A1 (en) 2010-10-28 2012-05-03 Aventis Pharma S.A. Semuloparin for the prevention of major venous thromboembolism in a patient undergoing major abdominal surgery
EP2446891A1 (en) 2010-10-28 2012-05-02 Aventis Pharma S.A. Semuloparin for use as an antithrombotic treatment in major abdominal surgery with improved safety in terms of clinically relevant bleedings and major bleedings
EP2548561A1 (en) 2011-07-22 2013-01-23 Aventis Pharma S.A. Semuloparin for improving the survival of patients with locally advanced cancer
ES2445494B1 (en) * 2012-08-02 2015-03-06 Rovi Lab Farmaceut Sa Procedure for obtaining low and very low molecular weight heparins
CN103175925B (en) * 2013-03-20 2014-12-03 山东辰中生物制药有限公司 Method for detecting esterification rate of heparin benzyl ester in production process of enoxaparin sodium
FR3016632A1 (en) * 2014-01-21 2015-07-24 IFP Energies Nouvelles PROCESS FOR TRANSFORMING POLYSACCHARIDES TO OXYGENIC MOLECULES IN THE PRESENCE OF NEUTRAL ORGANIC SUPERBASES
CZ306662B6 (en) * 2015-06-26 2017-04-26 Contipro A.S. Sulphated polysaccharides derivatives, the method of their preparation, the method of their modification and the use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2478646A2 (en) * 1980-03-20 1981-09-25 Choay Sa MUCOPOLYSACCHARIDIC COMPOSITION HAVING A COAGULATION REGULATING ACTIVITY, MEDICAMENT CONTAINING THE SAME, AND METHOD FOR OBTAINING THE SAME
IL61201A (en) * 1979-10-05 1984-09-30 Choay Sa Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them
FR2482611B1 (en) * 1980-05-14 1986-03-07 Pharmindustrie NOVEL SULFATED POLYSACCHARIDES, METHODS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS
US4916219A (en) * 1985-03-28 1990-04-10 University Of Iowa Research Foundation Oligosaccharide heparin fragments as inhibitors of complement cascade
EP0337327A1 (en) * 1988-04-09 1989-10-18 Bioiberica, S.A. Process for the preparation of new oligosaccharide fractions by controlled chemical depolimerization of heparin
ES2077533B1 (en) * 1994-02-28 1996-07-01 Bioiberica PROCEDURE FOR OBTAINING OLIGOSACCHARIDE FRACTIONS BY CHEMICAL DEPOLYMERIZATION OF HEPARIN.
ES2161615B1 (en) * 1999-07-23 2003-03-16 Rovi Lab Farmaceut Sa COMPOSITIONS OF HEPARINS OF VERY LOW MOLECULAR WEIGHT.
JP4897991B2 (en) * 1999-07-23 2012-03-14 ラボラトリオス ファルマセウティコス ロビ ソシエダッド アノニマ Ultra low molecular weight heparin composition

Also Published As

Publication number Publication date
MXPA03000579A (en) 2003-06-06
HUP0300755A3 (en) 2004-03-01
DE60142340D1 (en) 2010-07-22
ATE470679T1 (en) 2010-06-15
ES2347134T5 (en) 2014-06-24
HK1059273A1 (en) 2004-06-25
YU2903A (en) 2006-03-03
CL2004001154A1 (en) 2005-05-27
MA26928A1 (en) 2004-12-20
IL153922A (en) 2010-05-17
CA2416673A1 (en) 2002-01-31
FR2811992B1 (en) 2003-07-04
ZA200300898B (en) 2004-04-30
EA200300178A1 (en) 2003-06-26
IL153922A0 (en) 2003-07-31
ECSP034442A (en) 2003-03-10
NO20030296L (en) 2003-01-20
AU7760201A (en) 2002-02-05
AP2003002744A0 (en) 2003-03-31
AR029865A1 (en) 2003-07-16
PL365561A1 (en) 2005-01-10
AU2001277602B2 (en) 2007-07-19
KR20030040364A (en) 2003-05-22
AP1703A (en) 2007-02-26
TWI307278B (en) 2009-03-11
PT1307491E (en) 2010-09-10
CN1447820A (en) 2003-10-08
BR0112612A (en) 2003-07-29
DK1307491T3 (en) 2010-10-11
JP2004504451A (en) 2004-02-12
OA12340A (en) 2006-05-15
KR100853585B1 (en) 2008-08-21
EP1307491A1 (en) 2003-05-07
WO2002008295A1 (en) 2002-01-31
CY1110774T1 (en) 2015-06-10
SI1307491T1 (en) 2010-10-29
PL202471B1 (en) 2009-06-30
BR0112612B1 (en) 2011-07-12
DZ3411A1 (en) 2002-01-31
UA74836C2 (en) 2006-02-15
FR2811992A1 (en) 2002-01-25
EP1307491B2 (en) 2014-05-07
EP1307491B1 (en) 2010-06-09
HUP0300755A2 (en) 2003-12-29
NZ524028A (en) 2004-12-24
HRP20030019A2 (en) 2005-10-31
CN1230449C (en) 2005-12-07
EA005995B1 (en) 2005-08-25
ES2347134T3 (en) 2010-10-26
JP5279160B2 (en) 2013-09-04
CA2416673C (en) 2011-06-14

Similar Documents

Publication Publication Date Title
NO20030296D0 (en) Heparin-derived polysaccharide mixtures, their preparation and pharmaceutical compositions containing the compositions
DK1263720T3 (en) Acetidine derivatives, their preparation, and pharmaceutical compositions containing the same
NO20032187D0 (en) Heterocyclylalkylpiperidine derivatives, their preparation and preparations containing the compounds
NO324250B1 (en) Diazabicyclic compounds, pharmaceutical compositions comprising these and their use
NO20010013L (en) Sulfur-substituted sulfonylaminocarboxylic acid N-arylamides, their preparation and use as well as pharmaceutical preparations containing the compounds
NO20032438D0 (en) Ortho and Metasubstituted Bis-Aryl Compounds, Their Preparation and Use, and Pharmaceutical Preparations Containing the Compounds
NO20025450L (en) New pharmaceutical composition
ITTO20010005A0 (en) PHARMACEUTICAL FORMULATION.
NO20005146L (en) Thienylazolylalkoxyethanamines, their preparation and their use as drugs
DK1095025T3 (en) Benzimidazoles, their preparation and their use as drugs
NO20023400L (en) New compounds with hypolidemic and hypocholesterolemic effect, their preparation and preparations containing the compounds
NO20022021D0 (en) Indeno-, naphtho- and benzocyclohepta-dihydrotiazole derivatives, the preparation of the same and their use as anorexic drugs
IL150905A0 (en) Andrographolide derivatives and pharmaceutical compositions containing the same
NO20016247L (en) Streptogramin derivatives, their preparation and preparations containing the derivatives
NO20022022L (en) N-guanidinoalkylamides, their preparation, their use and pharmaceutical compositions comprising these
NO20003661L (en) New pentasaccharides, methods for their preparation and pharmaceutical preparations containing the same
DK1118610T3 (en) Benzenesulfonamide derivatives, process for their preparation and pharmaceutical compositions containing the derivatives
NO20024590D0 (en) Pharmaceutical preparations containing oligosaccharides, the new oligosaccharides and their preparation
IL173206A0 (en) Heparin-derived oligosaccharide mixtures, preparation thereof and pharmaceutical compositions containing said mixtures
NO20014692L (en) 3-amidinobenzenesulfonamide derivatives, medical compositions containing them and intermediates in the preparation thereof
IL154986A0 (en) Triazolo-epothilone derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof
DK1176148T3 (en) Benzothiadiazine Compounds, Methods of Preparation and Pharmaceutical Compositions Containing These
NO20004075D0 (en) Substituted pyrimidin-2-yloxy-carboxylic acid derivatives, their preparation and their use as endothelin antagonists
NO20020404L (en) Streptogramin derivatives, their preparation and preparations containing the derivatives
NO20022457L (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and their use as drugs

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application